ACM
AHCO icon

AlphaCrest Capital Management’s AdaptHealth AHCO Stock Holding History

AlphaCrest Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,885
Closed -$575K – 1261
2022
Q2 		$575K Buy
31,885
+10,229
+47% +$166K 0.03% 907
2022
Q1 		$347K Buy
21,656
+4,892
+29% +$88K 0.02% 1054
2021
Q4 		$410K Sell
16,764
-31,036
-65% -$729K 0.02% 1165
2021
Q3 		$1.11M Buy
47,800
+36,700
+331% +$887K 0.06% 566
2021
Q2 		$304K Buy
+11,100
New +$317K 0.01% 1101

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AlphaCrest Capital Management's AHCO Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of AdaptHealth (AHCO) in Q3 2022, closing a stake of 31,885 shares — an estimated $575K sold.

AlphaCrest Capital Management first reported a position in AHCO in Q2 2021 and held it in 5 quarters. The position peaked at $1.11M in Q3 2021. 184 funds tracked by Wall St. Rank hold AHCO as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining AdaptHealth position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 31,885 AdaptHealth shares in Q3 2022, an estimated $575K.
  • AlphaCrest Capital Management first reported a position in AdaptHealth in Q2 2021 and held it in 5 quarters.
  • AlphaCrest Capital Management's AdaptHealth position peaked at $1.11M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.